Literature DB >> 35066739

Study of the biological characteristics of human umbilical cord mesenchymal stem cells after long-time cryopreservation.

Mingqi Zhang1,2,3, Yan Zhao1,2, Le Wang1,2, Yuqiang Zheng1,2, Hui Yu1,2, Xiaoming Dong1,2, Wei He1,2,3, Zhengqin Yin4, Zhuoshi Wang5,6.   

Abstract

Human umbilical cord mesenchymal stem cells (hUC-MSCs) have considerable potential in cell therapy. Cryopreservation represents the gold standard in cell storage, but its effect on hUC-MSCs is still not well understood. The aim of this study was to investigate the effect of one year of cryopreservation and thawing on the biological characteristics of hUC-MSCs from the same donors. Fresh hUC-MSCs were cryopreserved in commercial freezing medium (serum-free CellBanker 2) at passage 2. After one year of cryopreservation, the hUC-MSCs were thawed and subcultured to passage 4. The comparison was performed in terms of followings: cell count, viability, morphology, proliferation capacity, differentiation potential and chromosomal stability. The total cell count and viability of hUC-MSCs before and after one year of cryopreservation were 1 × 107 and 96.34% and 0.943 × 107 and 93.81%, respectively. Cryopreserved and fresh hUC-MSCs displayed a similar cell doubling times, expressed the markers CD73, CD90, CD105 and were negative for the markers CD34, CD45, and HLA-DR. Karyotypes were found to be normal after one year of cryopreservation. The trilineage differentiation properties were maintained after cryopreservation. However, when compared to freshly isolated hUC-MSCs from the same donor, cryopreserved hUC-MSCs exhibited decreased expression of osteogenesis- and chondrogenesis-related genes including Runx2, Sox9, and Col1a1, and increased expression of adipogenesis-related genes. These results demonstrated that cryopreservation did not affect cell morphology, surface marker expression, cell viability, proliferative capacity, or chromosomal stability. However, the osteogenic and chondrogenic differentiation capacities of cryopreserved hUC-MSCs were slightly reduced compared with those of fresh cells from the same donor.
© 2021. The Author(s).

Entities:  

Keywords:  Cell proliferation; Cryopreservation; Human umbilical cord mesenchymal stem cells; Karyotype; Multilineage differentiation; Surface marker

Year:  2022        PMID: 35066739     DOI: 10.1007/s10561-021-09973-1

Source DB:  PubMed          Journal:  Cell Tissue Bank        ISSN: 1389-9333            Impact factor:   1.522


  17 in total

1.  Deleterious effects of freezing on osteogenic differentiation of human adipose-derived stromal cells in vitro and in vivo.

Authors:  Aaron W James; Benjamin Levi; Emily R Nelson; Michelle Peng; George W Commons; Min Lee; Benjamin Wu; Michael T Longaker
Journal:  Stem Cells Dev       Date:  2010-10-17       Impact factor: 3.272

2.  Cryopreservation of mouse adipose tissue-derived stem/progenitor cells.

Authors:  Koichi Oishi; Hirofumi Noguchi; Hiroshi Yukawa; Takamichi Miyazaki; Ryuji Kato; Yasuo Kitagawa; Minoru Ueda; Shuji Hayashi
Journal:  Cell Transplant       Date:  2008       Impact factor: 4.064

Review 3.  Human umbilical cord mesenchymal stem cells: an overview of their potential in cell-based therapy.

Authors:  Tan Li; Mingxu Xia; Yuanyuan Gao; Yanting Chen; Yun Xu
Journal:  Expert Opin Biol Ther       Date:  2015-06-12       Impact factor: 4.388

4.  Efficacy and Safety of Autologous Bone Marrow Mesenchymal Stem Cell Transplantation in Patients with Diabetic Retinopathy.

Authors:  Xianliang Gu; Xi Yu; Chen Zhao; Ping Duan; Tongtao Zhao; Yong Liu; Shiying Li; Zhi Yang; Yunyan Li; Cheng Qian; Zhengqin Yin; Yi Wang
Journal:  Cell Physiol Biochem       Date:  2018-08-22

5.  Effects of Freeze-Thawing and Intravenous Infusion on Mesenchymal Stromal Cell Gene Expression.

Authors:  Martin J Hoogduijn; Samantha F H de Witte; Franka Luk; Mirjam C G N van den Hout-van Vroonhoven; Lech Ignatowicz; Rusan Catar; Tanja Strini; Sander S Korevaar; Wilfred F J van IJcken; Michiel G H Betjes; Marcella Franquesa; Guido Moll; Carla C Baan
Journal:  Stem Cells Dev       Date:  2016-03-30       Impact factor: 3.272

Review 6.  Cryopreservation of Adipose-Derived Mesenchymal Stem Cells.

Authors:  Chika Miyagi-Shiohira; Kiyoto Kurima; Naoya Kobayashi; Issei Saitoh; Masami Watanabe; Yasufumi Noguchi; Masayuki Matsushita; Hirofumi Noguchi
Journal:  Cell Med       Date:  2015-08-26

7.  Platelet lysate from whole blood-derived pooled platelet concentrates and apheresis-derived platelet concentrates for the isolation and expansion of human bone marrow mesenchymal stromal cells: production process, content and identification of active components.

Authors:  Natalie Fekete; Mélanie Gadelorge; Daniel Fürst; Caroline Maurer; Julia Dausend; Sandrine Fleury-Cappellesso; Volker Mailänder; Ramin Lotfi; Anita Ignatius; Luc Sensebé; Philippe Bourin; Hubert Schrezenmeier; Markus Thomas Rojewski
Journal:  Cytotherapy       Date:  2012-02-02       Impact factor: 5.414

Review 8.  Review of Signaling Pathways Governing MSC Osteogenic and Adipogenic Differentiation.

Authors:  Aaron W James
Journal:  Scientifica (Cairo)       Date:  2013-12-12

9.  Toxicity Minimized Cryoprotectant Addition and Removal Procedures for Adherent Endothelial Cells.

Authors:  Allyson Fry Davidson; Cameron Glasscock; Danielle R McClanahan; James D Benson; Adam Z Higgins
Journal:  PLoS One       Date:  2015-11-25       Impact factor: 3.240

Review 10.  Clinical Translation of Mesenchymal Stromal Cell Therapy for Graft Versus Host Disease.

Authors:  Juliana A P Godoy; Raquel M A Paiva; Aline M Souza; Andrea T Kondo; Jose M Kutner; Oswaldo K Okamoto
Journal:  Front Cell Dev Biol       Date:  2019-11-21
View more
  1 in total

Review 1.  Spotlight on therapeutic efficiency of mesenchymal stem cells in viral infections with a focus on COVID-19.

Authors:  Saman Yasamineh; Hesam Ghafouri Kalajahi; Pooneh Yasamineh; Omid Gholizadeh; Hamed Rahmani Youshanlouei; Saeed Karimi Matloub; Masoud Mozafari; Elham Jokar; Yalda Yazdani; Mehdi Dadashpour
Journal:  Stem Cell Res Ther       Date:  2022-06-17       Impact factor: 8.079

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.